Five-Year Capital Spending Plan -- Remains at $1.9 billion, reaffirming a targeted 10% compounded annual rate base growth ...
Hosting the call today will be Beneficient's Interim CEO, James Silk. Following his remarks, Greg Ezell, Chief Financial Officer, will provide some financial highlights. I'll turn the call over to ...
The following is a transcript of my interview with registered dietician Jill Chodak on the importance of vitamin B12. It was ...
Thomas L. Deitrich, Itron, Inc.'s President and Chief Executive Officer, and Joan S. Hooper, Senior Vice President and Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results